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Summary
One of the methods for curing obesity is the inclusion of some substances with the antili-
pase activity in the diet and thus reducing the uptake of fat components from food. The aim of 
this research is to provide a stabilized form of lipase inhibitor by immobilization of enzyme on 
the biopolymers from Agaricus bisporus cell walls. The phenolic compounds extracted from 
the rapeseed were considered as the lipase inhibitor. The activity of the inhibitor was consider-
ably reduced in the gastric juice, as well as at temperatures above 37 °C and during its storage, 
which determined the suitability of the inhibitor for stabilization on the matrix. The effective-
ness of the phenolic compound stabilization was investigated by means of immobilization on 
the biopolymers from Agaricus bisporus cell wall matrix. The biopolymers used were β-glucan, 
chitin, melanin and proteins. A number of samples, which differed both in the content of the 
inhibitor (from 1 to 16 %) and in the ratio of biopolymers in the matrix composition, was ob-
tained. The conditions of immobilization (temperature, duration of the process) were also var-
ied. The expediency of obtaining the sample with the inhibitor content of 12 % and matrix 
containing 47.9 % of glucan, 18.8 % of chitin, 18.8 % of melanin and 11.1 % of proteins was 
shown. The best immobilization was carried out at 20–25 °C for 30 min. Thermal analysis and 
infrared spectroscopy data confirmed that immobilization of the lipase inhibitor on the matrix 
was due to the hydrogen bonds. The immobilized inhibitor had higher pH stability and higher 
thermal stability than the original one. The remaining activity of the immobilized inhibitor 
was higher than the original one after incubation in the gastric acid and bile. The immobilized 
inhibitor was characterized by a low loss of activity after 12 months of storage.
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Introduction
In recent decades, the population of many countries 
has faced the problem of obesity (1,2). For a long time we 
believed that it did not have a serious impact on the hu-
man health. However, at the turn of the 21st century, the 
World Health Organization has changed its opinion on 
this problem. The results of medical studies have shown 
that the chronic form of obesity is a disease associated 
with insulin-independent diabetes, hypertension, athero-
sclerosis, gallstone disease and some malignant diseases. 
In addition, the medical prognosis is unfavourable, as the 
number of patients that suffer from chronic obesity is in-
creasing; every second inhabitant of our planet will face 
this problem in 10 years (2-4).
In order to fight against this disease, scientists have de-
veloped the number of drugs. However, a detailed study of 
their impact on the human body revealed that only one of 
them is safe to use. It is a drug called Xenical (orlistat). This 
product is obtained by hydrogenation of lipstatin (5-7).
Orlistat inhibits the lipase activity in the human body. 
It reduces decomposition of exogenous fats and facilitates 
their excretion from the body. Thus, it shows antilipase ac-
tivity and reduces the digestibility of fat. However, in some 
cases, its application is accompanied by a violation of the 
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qualitative and quantitative composition of the intestinal 
microflora. This, in turn, can disrupt the balance of the en-
tire microbial-intestinal tissue complex (8). 
Inhibitors of pancreatic lipase derived from the plant 
sources have no side effects. They do not cause addiction 
or allergies and they are nontoxic, in contrast to microbial 
inhibitors (9). Therefore, the development of antilipase 
drugs produced from plant sources is relevant.
Some existing dietary supplements that contain plant 
components can inhibit the lipase action. They are manu-
factured in Indonesia and include products from leaves or 
extracts of Guazuma ulmifolia and Brassicaceae family 
plants. They show antilipase activity due to the phenolic 
compounds. When coffee beans and leaves of black and 
green tea are included in the dietary supplements, the al-
kaloids and the catechins of the raw materials are the active 
compounds inhibiting lipase (10-13). However, applica-
tion of some dietary supplements that contain the sources 
of lipase inhibitors listed above has several disadvantages. 
They have some antinutrients, such as the cyanogenic gly-
cosides and alkaloids (14,15).
Among the European plants, the plant families Legu-
minosae, Cruciferae, Papaveraceae, Apiaceae and Brassi-
caceae have the highest antilipase activity (10). However, 
due to the climate conditions, plants that grow in Europe 
have lower antilipase activity than Indonesian ones. The 
rapeseed, which belongs to the family Brassicaceae, is the 
prospective source of the compounds with antilipase ac-
tivity. The advantage of this culture as a raw material for 
producing lipase inhibitors is that the rapeseed is one of 
the most productive oilseed crops in the world. Therefore, 
in recent years, its cultivation area had increased. Further-
more, not only rapeseed but also some by-products of its 
processing can be used as a source of phenolic compounds.
The phenolic acids, as well as the soluble and insoluble 
tannins are the main carriers of the antilipase activity in the 
rapeseed (16,17). The phenolic acids derived from benzoic 
and cinnamic acids occur in the rapeseed in the free and 
bound forms. The sinapic acid and its derivative sinapine 
(choline ester of 3,5-dimethoxy-4-hidroxycinnamic acid) 
predominate among the phenolic acids in the rapeseed (18).
Direct addition of rapeseed into dietary supplements 
as a source of the lipase inhibitor is not recommended, due 
to its low content of phenolic compounds and antinutrient 
substances, particularly erucic acid and glycosinolates (10). 
The rapeseed phenolic compounds extracted from the raw 
materials are unstable and they rapidly lose their antilipase 
activity. Therefore, it is important to obtain the type of the 
inhibitor that will be resistant to external influences.
Immobilization is one of the well-known methods 
of stabilizing biologically active substances (19,20). Con-
sidering that the purpose of immobilization is to obtain 
the phenolic compounds that are resistant to the environ-
mental influence, we regarded biopolymers from Agaricus 
bisporus cell walls as a matrix (21), chosen for their anti-
oxidant and antacid properties. The first goal was to create 
the prerequisites for preserving the antilipase activity of 
the inhibitor during storage and the second to protect it 
against the influence of the acid medium during passage 
through the stomach.
The aim of this research is to obtain the stabilized 
form of the lipase inhibitor by its immobilization on the 
biopolymers from Agaricus bisporus cell walls.
Materials and Methods
Materials
All reagents and standards were obtained from Sig-
ma-Aldrich Corp. (St. Louis, MO, USA). Agaricus bispo-
rus was purchased at the farm that cultivates mushrooms, 
Geleka-M Company (Odessa, Ukraine). The fruiting bod-
ies were cleaned, dried and milled. The rapeseed (Brassica 
napus) was obtained from List Company (Kiev, Ukraine). 
The drug Xenical was from Roche (Basel, Switzerland).
Preparation of matrices for inhibitor immobilization
During the experimental research, samples of Agaricus 
bisporus biopolymers were used as a matrix for the inhibitor 
immobilization. Solid residues were obtained after the se-
quential treatment of the mushroom with three extraction 
agents: boiling water for 90 min, 3.7 % HCl at 25 °С for 150 
min and 3 or 7 % NaOH at 98 °C. The duration of the alka-
line treatment was 60 or 300 min (Table 1). The solid residue 
was washed until the neutral pH was obtained and then it 
was freeze dried. The matrix without melanin was obtained 
by the additional treatment of sample 5 (Table 1) with 8 % 
H2O2 solution for 60 min at room temperature. 
Table 1. Conditions used for obtaining samples of matrices

























































Determination of chemical composition of matrices
Matrices were treated with 72 % H2SO4 at room tem-
perature for 150 min. Water was added to decrease acid 
volume fraction to 5 %. Then the matrices were hydrolysed 
for another 300 min at the boiling temperature (22). Mela-
nin content was determined by UV-Vis spectrophotom-
eter (UV-2401 PC; Shimadzu Corp., Kyoto, Japan) at the 
wavelength λ=490 nm (23). The polysaccharide content 
(except chitin) was determined by the anthrone method. 
A volume of 4 mL of anthrone reagent (1 mg of anthrone 
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per 1 mL of H2SO4) was added to 0.5 mL of working so-
lution, the mixture was bathed for 15 min, cooled to the 
room temperature, and the absorbance was measured by 
UV-Vis spectrophotometer (UV-2401 PC; Shimadzu) at 
λ=670 nm (24). The glucosamine content was evaluated 
with 3-methyl-2-benzothiazolone hydrazone hydrochlo-
ride according to Lane Smith and Gilkerson (25). To 1 mL 
of the sample solution, 1 mL of 5 % KHSO4 and 1 mL of 5 % 
NaNO2 were added. The mixture was shaken at 5000 rpm 
for 15 min, then 1 mL of 12.5 % NH4SO3NH2 was added 
and shaken for 5 min. A volume of 1 mL of 0.5 % 3-methyl- 
-2-benzothiazolone-hydrazone-hydrochloride was added 
and the mixture was left to settle for 60 min. Then 1 mL of 
0.5 % FeCl3 was added and the absorbance was measured 
by UV-Vis spectrophotometer (UV-2401 PC; Shimadzu) at 
λ=650 nm.
The monosaccharides from the hydrolysates were con-
verted into their corresponding alditol acetates (26) and 
identified by gas-liquid chromatography (Hewlett-Packard 
5890 A chromatograph; Hewlett-Packard, St. Louis, MO, 
USA) with a flame ionization detector and integrator 3393 
A with an Ultra-1 capillary column (25 m×0.2 mm) at tem-
peratures from 175 to 270 °C and a rate of 10 °C/min in a 
stream of nitrogen. 
The content of nitrogen in protein was estimated as 
the difference between the total nitrogen determined by 
Kjeldahl method (27) and nitrogen in chitin. The content of 
nitrogen in chitin was estimated by dividing the chitin con-
tent by coefficient 6.89 (28). The total protein content was 
calculated by multiplying the protein nitrogen by 6.25 (27).
Inhibitor preparation
The precrushed and defatted rapeseed was treated with 
96 % ethanol at 30 °C for 30 min. The ethanol extract that 
contained the phenolic compounds was separated by cen-
trifugation at 5000 rpm (centrifuge model OS-6MC; Dastan, 
Kazakhstan). From this extract the ethanol was removed by 
vacuum distillation. The resulting residue was dissolved in 
water to obtain the mass per volume ratio of the inhibitor in 
the solution from 0.17 to 4.77 % (Table 2).
Determination of chemical composition of the inhibitor
The content of phenolic compounds was determined 
by Folin-Ciocalteu method (29). The composition of phe-
nolic compounds was determined by thin layer chroma-
tography (TLC) on CAMAG TLC Scanner 4 (Muttenz, 
Switzerland) apparatus equipped with automatic TLC 
Table 2. Conditions used for preparation of the immobilized inhibitor




Sample no. m/g w/% V/mL
1’ 1 1 0.99 0.25 4
1’ 4 1 0.96 1.04 4
1’ 7 1 0.93 1.88 4
1’ 10 1 0.90 2.78 4
1’ 12 1 0.88 3.41 4
1’ 14 1 0.86 4.07 4
1’ 16 1 0.84 4.77 4
2’ 1 2 0.99 0.25 4
2’ 4 2 0.96 1.04 4
2’ 7 2 0.93 1.88 4
2’ 10 2 0.90 2.78 4
2’ 12 2 0.88 3.41 4
2’ 14 2 0.86 4.07 4
2’ 16 2 0.84 4.77 4
3’ 1 3 0.99 0.17 6
3’ 4 3 0.96 0.69 6
3’ 7 3 0.93 1.25 6
3’ 10 3 0.90 1.85 6
3’ 12 3 0.88 2.27 6
3’ 14 3 0.86 2.71 6
3’ 16 3 0.84 3.17 6
4’ 1 4 0.99 0.17 6
4’ 4 4 0.96 0.69 6
4’ 7 4 0.93 1.25 6
4’ 10 4 0.90 1.85 6
4’ 12 4 0.88 2.27 6
4’ 14 4 0.86 2.71 6
4’ 16 4 0.84 3.17 6
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sampler 4, twin trough chamber (20 cm×10 cm), chroma-
togram immersion device III, TLC plate heater III, auto-
matic development chamber ADC2 and visualizer. The 
mobile phase was benzene/ethanol/acetic acid in a volume 
ratio of 90:16:9. The phenolic compounds were visualized 
by spraying the plates with water solution of ferrum chlo-
ride and ferrocyanide potassium (30). The sinapine and 
sinapic acid were identified by comparing the Rf value (dis-
tance eluent travels was 10 cm) of the standard substances. 
The quantitative content of the sinapine and sinapic acid 
was perfomed by CAMAG TLC Scanner 4 apparatus. 
Additionally, the phenolic compounds were separated by 
TLC as described above, but the plate was not sprayed 
with water solution of ferrum chloride and ferrocyanide 
potassium. The spots of synapine and synapic acid were 
determined from the Rf value. These phenolic compounds 
were extracted with 96 % ethanol at 30 °C for 30 min and 
their antilipase activity was determined (31).
Determination of lipase and antilipase activity
The lipase activity was determined according to the 
method of Jagdish et al. (32) with some modifications. The 
lipase (from porcine pancreas) was prepared at the concen-
tration of 2.5 mg/mL. The substrate was prepared by mixing 
100 mL of olive oil and 150 mL of 2 % polyvinyl alcohol. 
The experimental sample was prepared as follows: 5 
mL of the substrate and 4 mL of phosphate-citrate buffer 
(pH=7) were placed in the flask and kept at 37 °C for 15 
min. After that, 1 mL of the enzyme solution was added to 
the mixture and mixed thoroughly. The resulting mixture 
was kept at 37 °C for 60 min. Then, 30 mL of 90 % ethanol 
were added to the mixture immediately to stop the reac-
tion. Using phenolphthalein solution as the indicator, the 
solution was titrated with 0.05 M NaOH solution until a 
pink colour was obtained. 
The control sample was prepared as follows: the mix-
ture of the substrate and phosphate-citrate buffer (pH=7) 
was kept at 37 °C. Then 30 mL of 90 % ethanol and 1 mL 
of the enzyme solution were added and the mixture was 
titrated immediately. 
The lipase activity (in U/g) was calculated according 
to the formula:
 Lipase activity=(V1-V2)·V3·50/γ /1/
where V1 is the volume of 0.05 M NaOH solution (in 
mL) used for the experimental sample titration, V2 is the 
volume of 0.05 M NaOH (in mL) used for the control 
sample titration, V3 is the titter of 0.05 M NaOH (in mL) 
and γ is the concentration of the enzyme in the reaction 
mixture (in g/mL).
The lipase activity in the presence of the inhibitor was 
assayed as described above. A distinction was that the in-
hibitor containing 0.5–8.0 mg of the phenolic compounds 
was added to the mixture at once after adding the enzyme 
solution (in experimental and control samples), and then 
the mixture was stirred thoroughly. 
The antilipase activity of the inhibitor and Xenical was 
determined as the difference between the values of the li-
pase activity in the enzyme solution and the lipase activity 
in the enzyme solution in the presence of 20 mg of Xenical.
Determination of inhibitor properties
For determination of the pH stability of the inhibi-
tor, 6 mg of the inhibitor were incubated in 100 mL of the 
medium with different pH values (HCl-KCl, pH=2; citrate 
buffer, pH=5; sodium phosphate buffer, pH=7 and Tris- 
-HCl, pH=9) for 0–360 min at (37±2) °C. The samples were 
taken every 60 min, the pH of the mixture was adjusted to 
pH=7, and the antilipase activity of the samples was de-
termined. 
To determine the thermal stability of the inhibitor, 6 
mg of the inhibitor were incubated at (20±2), (37±2) and 
(65±2) °C for 0–360 min. The samples were taken every 
60 min, their temperature was adjusted to (37±2) °C, and 
the antilipase activity of the samples was determined. Re-
maining antilipase activity in that test, as well as those 
described below, were estimated as the percentage of the 
initial value of the antilipase activity of the inhibitor.
To predict the preservation of antilipase activity in 
the gastrointestinal tract, 6 mg of inhibitor were placed in 
a flask and incubated in 100 mL of gastric juice at (37±2) 
°C for 180 min. After that, the pH in the flask was adjusted 
to pH=8 and 100 mL of the natural bile were added. The 
mixture was incubated at (37±2) °C for 180 min. The in-
hibitor was kept in the gastric juice and bile, the samples 
were taken every 60 min, the pH of the medium was ad-
justed to pH=7 and the antilipase activity of the inhibitor 
was determined. 
To determine the changes in antilipase activity during 
storage, 6 mg of the inhibitor were incubated for 7 days at 
(20±2) °C and relative humidity of 75 %. The antilipase ac-
tivity was determined after 6 h and then after 1, 3, 5 and 7 
days.
Preparation of the immobilized lipase inhibitor
To immobilize the phenolic compounds, the biopoly-
mer matrix was impregnated with their solution. The con-
tent of the inhibitor in samples 1’–4’ varied in the range 
from 1 to 16 % (Table 2). For preparing samples 1’ and 2’, 4 
mL of the inhibitor solution (with a mass per volume ratio 
of 0.25 to 4.77 %) were mixed with 1 g of matrices 1 and 2. 
For preparing samples 3’ and 4’, 6 mL of the inhibitor solu-
tion (with a mass per volume ratio of 0.17 to 3.17 %) were 
mixed with 1 g of matrices 3 and 4 (Table 2). The immobi-
lization temperature was varied from 20 to 40 °C during 
50 min of immobilization, and the immobilization time 
was varied from 10 to 50 min at the temperature of 25 °C.
Determination of antilipase activity of the 
immobilized inhibitor 
The antilipase activity of the immobilized inhibitor 
was determined as the difference between the lipase ac-
tivity value of the enzyme solution (as described above) 
and the lipase activity value of the enzyme solution in the 
presence of 50 mg of samples 1’–4’ (all containing 12 % of 
the inhibitor). The lipase activity of the enzyme solution in 
the presence of samples 1’–4’ was determined in the same 
way as described for the original inhibitor. The antilipase 
activity of the immobilized inhibitor was calculated as a 
percentage of the activity of the original inhibitor.
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Determination of immobilized inhibitor properties
The thermal and pH stability of the immobilized in-
hibitor (samples 1’–4’ with 12 % of the inhibitor), as well 
as its remaining activity in the gastrointestinal tract were 
determined in the same way as the original inhibitor. To 
determine the pH stability and thermal stability, 50 mg of 
samples 1’–4’ were used. For determination of the changes 
in the antilipase activity during storage, 50 mg of samples 
1’–4’ were kept for 12 months at (20±2) °C and air humid-
ity of 75 %. Every two months, their antilipase activity was 
determined. The remaining antilipase activity of the im-
mobilized inhibitor in these tests was calculated as a per-
centage of the activity of the original inhibitor.
Infrared spectroscopy and thermal analysis of the 
immobilized inhibitor 
Infrared (IR) spectroscopic study of the original inhib-
itor and samples 1’–4’ with 12 % of the inhibitor was car-
ried out using the FTIR-8400S Fourier transform IR spec-
trophotometer (Shimadzu Corp.) in the range of 4000–400 
cm-1. The IR spectra were compared according to Bikales 
and Segal (33). Differential thermal analysis of the mix-
ture of the inhibitor and samples 1–4 and 1’-4’ with 12 % 
of inhibitor was carried out on the MOM derivatograph 
Q-1500 D (Paulik-Paulik-Erdey, Budapest, Hungary) (34). 
The samples were placed in an alumina cup and heated 
from 20 to 900 °C at a heating rate of 5 °C/min in a nitro-
gen atmosphere. The flushing gas was passed through dry 
nitrogen at a rate of 100 mL/min.
Statistical analysis
The statistical analysis of the data was carried out by 
the dispersion and correlation analysis (35). The statisti-
cal differences were considered significant at p<0.05. The 
results are expressed as mean values±standard deviation 
(S.D.).
Results and Discussion
Inhibitor composition and its properties
The rapeseed contained 7.2 mg/g of the phenolic com-
pounds extracted with 96 % ethanol. Six phenolic com-
pounds in the extract were found by TLC method. Sinap-
ine (5.9 mg per g of seed) and sinapic acid (0.7 mg per g of 
seed) were dominant among them. The antilipase activity 
of the extract was 29 800 U per g of phenolic compounds, 
including the activity of sinapine, which was 18 200 U per 
g of phenolic compounds, and the activity of sinapic acid, 
which was 9700 U per g of phenolic compounds. The an-
tilipase activity of the phenolic compounds isolated from 
the rapeseed was comparable to that of the drug Xenical 
(9800 U/g). For this reason, it was expedient to obtain the 
dietary supplements with antilipase activity.
The lipase interacts with the lipids in the intestine 
(17), so the activity of the inhibitor must move along the 
digestive tract through the stomach (pH~2.0) and the in-
testine (pH~9.0). Thus, the inhibitor stability under these 
conditions was an important factor.
As it is shown in Fig. 1, at pH=2 the antilipase activity 
decreased after incubation for 60 min, then after 180 min 
it decreased 1.6 times and finally after 360 min only 40.2 
% of the initial inhibitor antilipase activity remained. At 
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Fig. 1. The stability of samples 1’–4’ at pH values of: а) 2.0, b) 5.0, 
c) 7.0 and d) 9.0
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b)
Fig. 3. Stability of samples 1’–4’ at temperatures of: а) (20±2), b) 
(37±2) and c) (65±2) ºС
higher. They were stable at pH=7 and 9 for 180 min. How-
ever, when the incubation time increased, the antilipase 
activity significantly decreased. Thus, it was necessary to 
use aqueous solution of phenolic compounds (pH=7) for 
the immobilization on the matrix.
Preservation of the antilipase activity of phenolic 
compounds during the contact with the gastric juice and 
bile was also studied. As can be seen from the data in Fig. 
2, the antilipase activity of phenolic compounds decreased 
mainly during the contact with the gastric juice. The bile 
had less effect on the antilipase activity. The residual ac-
tivity of the inhibitor was low (40.4 % of the initial value). 




Fig. 2. Changes in the antilipase activity of samples 1'–4' under the conditions simulating normal 
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Fig. 2. Changes in the antilipase activity of samples 1'–4' under the conditions simulating normal 


















sample 1´ sample 2´ sample 3´



















sample 1´ sample 2´ sample 3´
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We also studied the temperature effect on the antili-
pase activity of the inhibitor. It was important to predict 
the inhibitor stability in the human body when choosing 
the temperature conditions during preparation, drying 
and storing the samples of the immobilized inhibitor.
It was shown that the lipase inhibitor was stable at 
(20±2) °C for 120 min of incubation (Fig. 3). However, 
when the phenolic compounds were kept at the same tem-
perature for a long time, their activity was significantly 
reduced. If the phenolic compounds extracted from the 
rapeseed were kept at (20±2) °C for 6 h, their antilipase 
activity was reduced by 26.0 % of the initial value. When 
incubation temperature increased, the antilipase activity 
of phenolic compounds decreased after 60 min. Thus, it 
was necessary to investigate the influence of temperature 
in the range from 20 to 40 °C on the immobilization of 
phenolic compounds on the matrix, and on drying of the 
immobilized inhibitor at (65±2) °C.
a)
b)
Fig. 2. Changes in the antilipase activity of samples 1’–4’ under the 
conditions simulating normal digestion in: а) gastric juice and b) 
bile When the phenolic compounds were stored at (20±2) 
°C and relative humidity of 75 %, their antilipase activity de-
creased by 32.1 % after 1 day, by 51.4 % after 3 days, by 69.1 
% after 5 days and by 85.0 % of the initial value after 7 days.
Thus, phenolic compounds extracted from the rape-
seed inhibited the activity of pancreatic lipase. However, 
their effect was significantly reduced in the acid medium 
at pH=2. In addition, the antilipase activity of the inhibitor 
significantly decreased at higher temperature, as well as 
during the long-term storage at (20±2) °C. This indicates 
out the necessity to stabilize the phenolic compounds.
Immobilization of lipase inhibitor on the matrices
Stabilization of the inhibitor was carried out by its im-
mobilization on a matrix of Agaricus bisporus cell walls. 
Their chemical composition was shown in Table 3. They 
present a complex of biopolymers: polysaccharides, mela-
nin and proteins. Samples 1–4 were obtained under differ-
ent conditions and therefore the ratio of their components 
differed. In the polysaccharide hydrolyzate, only glucose 
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sure)/min Glucan Chitin Protein Melanin
1
3
60 56.5±1.2 14.0±0.3 11.5±0.2 13.8±0.3
2 300 59.8±1.3 15.8±0.3 9.2±0.2 11.9±0.2
3
7
60 47.9±1.0 18.8±0.4 11.1±0.2 18.8±0.4
4 300 38.8±0.8 41.7±0.8 3.0±0.1 13.6±0.3
Data are expressed as mean value±S.D. of triplicate measurements
and glucosamine were detected by by gas liquid chroma-
tography. Therefore, we concluded that polysaccharides 
were represented by glucan and chitin, which dominated 
in the samples (66.7–80.5 %). Chitin, compared to the 
other matrix components, is insoluble in the alkaline solu-
tions. Therefore, the increase of the mass per volume ratio 
of the alkaline solution and extraction time increased the 
extraction of glucan and proteins. As a result, chitin con-
tent in the samples increased. This was especially clear in 
sample 4, which was obtained by using the alkaline solu-
tion with a maximum mass per volume ratio (7.0 %) and 
extraction time (300 min).
Effect of inhibitor content and chemical composition 
of the matrix on antilipase activity of immobilized 
inhibitor
The original inhibitor was stable at 20–25 °C for 60 
min (Fig. 3). That is why its immobilization was carried out 
under these conditions.
The samples of the immobilized inhibitor 1’–4’ were 
obtained as a result of the inhibitor interaction with matri-
ces 1–4. The influence of the inhibitor content in the matrix 
on the antilipase activity of the immobilized inhibitor is 
shown in Table 4. When the content of the inhibitor in the 
sample increased, the antilipase activity of the immobilized 
inhibitor also increased. When the inhibitor content was 12 
%, the antilipase activity of the immobilized inhibitor ex-
ceeded the activity of the original inhibitor in all samples. In 
samples 3’ and 4’ this effect was observed even if the content 
of the inhibitor in the sample was lower. A further increase 
in the inhibitor content to 16 % did not lead to a significant 
change in the antilipase activity of the samples. Based on 
the obtained data, it was concluded that samples 1’-4’ with 
12 % inhibitor should be used in the following experiments.
To objectively understand these results, additional 
studies were carried out. It was shown that matrices 1–4 
had antilipase activity. In their presence, the hydrolysabil-
ity of olive oil by lipase was reduced by 7.2–8.1 %. Sample 3 
had the maximum antilipase activity. After the removal of 
melanin from matrix 3, matrix 5 was obtained and the im-
mobilization of the inhibitor in the mass per volume ratio of 
7 % was carried out on it. The antilipase activity of this sam-
ple was 1.3 times lower than that of sample 3’, and it made 
up 80.5 % of antilipase activity of the original inhibitor.
The high antilipase activity of the immobilized inhibi-
tors 1’–4’ was probably due to the synergistic effect, which 
was a result of the simultaneous presence of rapeseed phe-
nolic compounds and Agaricus bisporus melanin. Melanin 
is classified as the condensed phenolic compound, which 
was confirmed by the fact that sample 3, with the highest 
content of melanin, had the maximum antilipase activity.
Effect of immobilization conditions on antilipase 
activity of the immobilized inhibitor 
The analysis shows that the temperature of 20–25 °C 
was the most favourable for immobilization, preserving 
the antilipase activity of the obtained samples (Fig. 4a). 
When the immobilization temperature increased, the an-
tilipase activity of the immobilized inhibitor consistently 
decreased. This fact was observed in all used matrices. 
It was concluded that the increase of the immobilization 
temperature most probably contributes to the destruction 
of labile phenolic compounds (15,17).
Таble 4. The antilipase activity of the immobilized inhibitor 
w(inhibitor)/%
Antilipase activity/%
1’ 2’ 3’ 4’
1 90.1±1.8 88.1±1.7 94.3±1.9 91.3±1.8
4 90.4±1.9 88.3±1.7 95.3±1.9 91.6±1.8
7 90.8±1.7 88.9±1.8 104.7±2.0 91.9±1.8
10 100.4±2.0 95.8±1.9 116.9±2.2 104.3±2.0
12 112.7±2.2 103.1±2.0 123.4±2.3 116.2±2.2
14 112.4±2.3 102.8±2.1 123.0±2.3 117.6±2.3
16 112.8±2.3 101.6±2.0 122.3±2.2 117.0±2.2
Data are expressed as mean value±S.D. of triplicate measurements
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tained 12 % of the inhibitor) and the mixture of the inhibi-
tor and samples 1–4 was detected because of the removal 
of free moisture, followed by the endothermic effect. 
When the temperature reached 360 °C, the mass reduc-
tion of only the immobilized inhibitor was detected, fol-
lowed by exothermic effect. This effect was not observed 
when the mixture of the inhibitor and samples 1–4 was 
used. An additional exothermic effect at 360 °C of the im-
mobilized inhibitor was probably caused by the destruc-
tion of the inhibitor-matrix bonds, which confirmed the 
immobilization of the inhibitor on the matrix. At higher 
temperature, the abrupt decrease in the mass of both the 
immobilized inhibitor and the mixture of the inhibitor and 
samples 1–4 was detected due to their destruction. Since 
the samples taken for the study contain the same amount 
of the inhibitor, there was no significant difference in their 
characteristics evaluated using this method. The results 
of thermal analysis and IR spectroscopy confirmed that 
immobilization of the lipase inhibitor on the matrix took 
place and that the inhibitor-matrix complex was formed 
by hydrogen bonds.
As it is known, the immobilization methods can be 
divided into chemical and physical methods. Physical 
methods are characterized by weaker interactions such 
as hydrogen bonds, hydrophobic interactions, Van der 
Waals forces, affinity binding, or mechanical containment 
of biologically active substance within the matrix. In the 
chemical method, formation of covalent bonds is achieved 
through ether, thioether, amide or carbamate bonds be-
tween the biologically active substance and matrix (36). 
There are four principal techniques for immobilization of 
the biologically active substance, namely adsorption, en-
trapment, covalent bonding and cross-linking (36). Thus, 
on the basis of the obtained data, it can be concluded that 
the adsorption took place during immobilization of the in-
hibitor on the matrix.
Properties of the immobilized inhibitor 
The pH stability, thermal stability and the stability of 
the inhibitor immobilized on biopolymer matrix during 
storage were evaluated. Immobilized inhibitor samples 
1’–4’ with 12 % of the inhibitor were used. It was found 
that after 360 min of incubation at pH=2, the antilipase 
activity of the immobilized inhibitor was more than twice 
higher than the activity of the original inhibitor (Fig. 1), 
which was also the case after incubation in the medium 
with a higher pH.
It was determined that samples 3’ and 4’ had maxi-
mum stabilizing effect in comparison with other samples 
of immobilized inhibitor. In the acid medium at pH=2 and 
alkaline medium at pH=9, their antilipase activity was 1.3 
times higher than of samples 1’ and 2’.
However, the pH stability data of the immobilized in-
hibitor were not sufficient to predict the preservation of 
its biological activity in the digestive tract. That is why the 
influence of the solutions that simulate liquid media of the 
gastrointestinal tract on the stability of immobilized in-
hibitor was studied.
The obtained results correspond to the data on the pH 
stability of the immobilized inhibitor samples (Fig. 2). The 
a)
b)
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Fig. 4. The effect of immobilization conditions on the antilipase ac-
tivity of samples 1’–4’: а) temperature and b) time
a)
b)
When the immobilization time was increased up to 
30 min, the antilipase activity of the immobilized inhibitor 
also increased (Fig. 4b). During this time the phenolic com-
pound solution probably penetrated into the matrix, which 
improved the efficiency of immobilization. Increasing the 
duration of the process by more than 30 min did not give a 
positive result. Thus, it was expedient to carry out immobi-
lization at the temperature of 20–25 °C for 30 min.
Binding of inhibitor immobilization in the matrix
To confirm the inhibitor binding, the process of in-
hibitor immobilization was analyzed on sample 3. After the 
contact of sample 3’ (containing 12 % of the inhibitor) with 
water at (37±2) °C during 2 h, only 4 % of the initial phenolic 
compounds were found in the obtained solution. The phe-
nolic compounds that passed into the solution showed no 
antilipase activity. Thus, it was concluded that the matrix 
completely adsorbed the phenolic compounds with antili-
pase activity. 
When comparing the IR spectra of the original inhibitor 
and the immobilized inhibitor (samples 1’–4’ with 12 % of 
the inhibitor), it was found that the intense broad band with 
a maximum absorption at 3400 cm-1 was shifted to the low 
frequency region in comparison with the frequency of free 
OH groups. This indicated the presence of hydroxyl groups 
in hydrogen bonds. The intensity of the absorption bands at 
1648–1690 cm-1 decreased. The absence of an absorption 
band of 3650 cm-1 led to the conclusion that practically all 
hydroxyl groups were part of the formed hydrogen bond.
The differential thermal analysis data are given in Ta-
ble 5. At temperatures of 100 to 120 °C, the mass reduction 
of both the immobilized inhibitor (samples 1’–4’ that con-
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antilipase activity of the immobilized inhibitor was 2.0–2.6 
times higher than that of the original one. This fact made 
possible to predict preservation of high activity of the im-
mobilized inhibitor in human digestive tract. 
The significant increase in the stability of phenolic 
compounds as a result of immobilization was probably due 
to the fact that matrices 1–4 contained chitin. This poly-
saccharide consists of N-acetyl-d-glucosamine units. Dur-
ing alkaline treatment of the samples at high temperature, 
deacetylation took place and amino groups are released 
(19). As a result of this process, the matrix shows antacid 
properties, which are the result of the substance ability to 
increase the pH value of acid medium. Matrices 3 and 4 
were obtained by long-term alkaline treatment (300 min) 
and, as it was shown in a previous study (21), these matri-
ces contained more amino groups than matrices 1 and 2. 
As a result, matrices 3 and 4 had more pronounced antacid 
properties than matrices 1 and 2, and they better preserve 
the properties of phenolic compounds in acid medium.  
Thermal stability of the inhibitor also increased as a 
result of its immobilization (Fig. 3). High antilipase activ-
ity of samples 1’–4’ at (37±2) °C for 6 h was observed. That 
is why at the temperature of the human body they show 
the antilipase activity. After incubation of the original in-
hibitor at (65±2) °C for 360 min, its residual antilipase ac-
tivity was 30 %, which was 2.7–3.5 times lower than the 
residual activity of the immobilized inhibitor. The samples 
1’–4’ were  stable at (65±2) °C. That is why we recommend 
them for dry use by both freeze drying and spray drying. 
The thermal and the pH stability of samples 3’ and 4’ were 
higher than of samples 1’ and 2’.
Another important characteristic of the immobilized 
inhibitor was the preservation of its antilipase activity 
during storage. After 6 months of storage, the antilipase 
activity of samples 1’–4’ with 12 % of the inhibitor was 
88.5–112.8 % of the activity of the original inhibitor, but 
the original inhibitor lost 85.0 % of its activity after 7 days 
of storage (Fig. 5). After 6 months of storage, samples 2’ 
and 4’ had the highest antilipase activity. After 12 months 
of storage, the antilipase activity of samples 1’–4’ remained 
at a high level, but of sample 4’ was significantly higher 
than of other samples.
The stability of samples of the immobilized inhibitor 
with the increase of temperature to (37±2) and (65±2) °C, as 
well as during long-term storage at (20±2) °C was stipulated 
by the fact that the matrix prevented the transformation of 
rapeseed phenolic compounds. As it is known, the change 
in the phenolic compounds structure led to the loss of their 
properties. As a result, the phenolic compounds did not 
show any antilipase activity. Such transformation of their 
properties could be the result of the oxidation due to con-
tact with oxygen from the air (17).
As it is shown in a previous study (21), matrices 1–4 
had high antioxidant properties. Such properties can be ex-
plained by the presence of melanin in their composition and 
free amino groups in the chitin molecule. Therefore, they 
were able to inhibit the oxidation of rapeseed phenolic com-
pounds in contact with oxygen from the air and preserve 
their antilipase activity.
Analyzing the obtained results, it should be noted that 
high pH stability, thermal stability and stability of the im-
mobilized inhibitor during storage were related to the prop-
Table 5. Thermal effects of samples 1’–4’
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use of the obtained results for the development of produc-
tion technology, it is economically viable to obtain sample 
3’, since the use of longer treatment at high temperature 
will lead to the increase of the obtained product cost.
Conclusions
The stabilized form of lipase inhibitor was obtained 
by its immobilization on the biopolymers from Agaricus 
bisporus cell walls. It had significantly better pH and ther-
mal stability than the original inhibitor. It was stable under 
the conditions of the digestive tract. The immobilized in-
hibitor retained the activity for a long time during storage. 
The sample that had 12 % of the inhibitor and the matrix 
containing 47.9 % glucan, 18.8 % chitin, 18.8 % melanin 
and 11.1 % proteins showed the best characteristics. The 
best immobilization was carried out at 20–25 °C for 30 
min. The hydrogen bonds between the inhibitor and the 
matrix were formed during immobilization.
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